Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission ...Middle East

TORONTO, Sept. 10, 2026 /PRNewswire/ -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has filed a preliminary short...

Hence then, the article about cardiol therapeutics files us 150 million preliminary base shelf prospectus including additional disclosure following review by staff of the ontario securities commission was published today ( Friday 11/09/2026 - 12:11 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission )

Also on site :

• Yemen’s Houthis Seize Strategic Red Sea Port, Officials Say
• Fenerbahçe Face Roma Today: Kickoff Time and TV Channel Details
• Saudi Arabia’s ‘Muslim NATO’ faces its first trial by fire